CCRNHealthcare · Medical Care FacilitiesCCRN Stock Forecast: Cross Country Healthcare, Inc. Price Predictions for 2026-2027
The 7 Wall Street analysts covering Cross Country Healthcare, Inc. hold a median 12-month price target of $13 — +0.0% from the last close.
CCRN stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Cross Country Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
We don’t hold a current model rank for this company.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
CCRN stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on CCRN, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
The green dot is the last close — the median target sits 0.0% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 8 June 2026 | Barrington Research | Maintains | Market Perform | $13 |
| 8 June 2026 | Barrington Research | Maintains | Market Perform | — |
| 11 May 2026 | Truist Securities | Maintains | Hold | — |
| 8 May 2026 | Benchmark | Downgrade | Hold | — |
| 7 May 2026 | Wedbush | Downgrade | Neutral | — |
| 19 Mar 2026 | Wedbush | Upgrade | Outperform | — |
| 5 Mar 2026 | Benchmark | Upgrade | Buy | — |
| 3 Feb 2026 | Wedbush | Initiates | Neutral | — |
| 9 Dec 2025 | UBS | Maintains | Neutral | — |
| 17 June 2025 | Barrington Research | Maintains | Market Perform | — |
| 13 May 2025 | UBS | Maintains | Neutral | — |
| 14 Mar 2025 | Barrington Research | Maintains | Market Perform | — |
| 6 Feb 2025 | JMP Securities | Reiterates | Market Perform | — |
| 10 Dec 2024 | Barrington Research | Downgrade | Market Perform | — |
| 5 Dec 2024 | Truist Securities | Maintains | Hold | — |
| 7 Nov 2024 | Benchmark | Maintains | Buy | — |
| 21 Oct 2024 | Truist Securities | Maintains | Hold | — |
| 8 Aug 2024 | Barrington Research | Maintains | Outperform | — |
| 1 Aug 2024 | Truist Securities | Maintains | Hold | — |
| 6 May 2024 | Barrington Research | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CCRN appears on the weeks it earns a place.
CCRN analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Cross Country Healthcare, Inc. (CCRN) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 48.3×
- Price / sales
- 0.4×
- Price / book
- 1.3×
- EV / EBITDA
- 23.0×
Cheaper than 15% of US stocks
Cheaper than 85% of US stocks
Cheaper than 63% of US stocks
Cheaper than 13% of US stocks
- Revenue growth (YoY)
- −17.8%
- Earnings growth (YoY)
- −17.8%
- Gross margin
- 19.7%
- Operating margin
- −0.8%
- Net margin
- −9.8%
Higher than 12% of US stocks
Higher than 21% of US stocks
Higher than 21% of US stocks
Higher than 31% of US stocks
Higher than 20% of US stocks
- Return on equity
- −27.0%
- Return on assets
- −0.1%
- Dividend yield
- —
Higher than 28% of US stocks
Higher than 43% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Cross Country Healthcare, Inc. (CCRN) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Cross Country Healthcare, Inc. has a market value of $428.1M and an enterprise value of $324.9M.
Revenue in the twelve months to 31 Mar 2026: $1.0B. The latest quarter shrank 17.8% year on year.
Net income over the same four quarters: −$98.6M, a −9.8% net margin.
Diluted earnings per share, trailing twelve months: $−3.05.
Free cash flow in the twelve months to 31 Mar 2026: $39.6M, after $7.7M of capital spending.
Cross Country Healthcare, Inc. spent $12.4M on share buybacks in the twelve months to 31 Mar 2026.
Trailing P/E: 48.3×; forward P/E: 45.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Cross Country Healthcare, Inc. employs 7,890 people — $127K of revenue per employee.
Data provided by Twelve Data
CCRN vs competitors
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| CCRNCross Country Healthcare, Inc. | $428.1M | — |
| LLYEli Lilly & Co.* | $1.2T | 91 |
| JNJJohnson & Johnson* | $650.8B | 92 |
| ABBVAbbVie, Inc.* | $468.1B | 96 |
| MRKMerck & Co., Inc.* | $378.6B | 83 |
| UNHUnitedHealth Group, Inc.* | $353.4B | 75 |
| AMGNAmgen, Inc.* | $236.8B | 92 |
* Nearest Healthcare names by size — few medical care facilities companies of this scale trade in the US universe.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Cross Country Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about CCRN stock
What is the CCRN stock price forecast for 2026-2027?
The 7 Wall Street analysts covering Cross Country Healthcare, Inc. have a median 12-month price target of $13, with estimates ranging from $10 to $13. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is CCRN stock a buy right now?
Of the 7 analysts covering Cross Country Healthcare, Inc., 0 rate it a Buy, 7 a Hold and 0 a Sell. None of this is personal advice — it does not consider your circumstances.
Will CCRN stock go up?
No one can know that. What the data says: the median 12-month target from 7 analysts implies +0.0% from the last close. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the CCRN stock forecast for 2030?
No analyst covering Cross Country Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CCRN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $13 over the next 12 months.
What does Cross Country Healthcare, Inc. do?
Cross Country Healthcare Inc. is a leading provider of workforce solutions to the healthcare sector in the United States.
About Cross Country Healthcare, Inc.
Cross Country Healthcare Inc. is a leading provider of workforce solutions to the healthcare sector in the United States. Its primary function is to offer staffing services including travel nurse and allied health staffing, per diem and permanent placement, as well as workforce management solutions to hospitals and healthcare facilities nationwide. This company plays a vital role in ensuring healthcare facilities can maintain optimal staffing levels, enhancing patient care and healthcare delivery across various settings. Cross Country Healthcare Inc. has an impactful presence in areas such as nursing, emergency medicine, and allied health, addressing the critical demand for healthcare professionals. By partnering with healthcare providers and professionals, Cross Country Healthcare actively contributes to mitigating staffing shortages and improving healthcare accessibility. Established in Boca Raton, Florida, the company leverages its industry expertise and expansive network to deliver comprehensive staffing solutions, making it a crucial component of the healthcare industry’s operational framework.
CEO Mr. John A. Martins · 7,890 employees · United States · https://www.crosscountry.com